Effects of Otago and Gaze Stabilization Exercises on Balance, Gait and QOL in Elderly Stroke Patients
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Feb 20, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how two types of exercises—Otago exercises and Gaze Stabilization exercises—can help improve balance, walking, and overall quality of life in elderly patients who have had a stroke. The researchers want to see which of these exercise programs is more effective for people recovering from a stroke, specifically looking at their ability to keep their balance and walk better.
To participate in the trial, individuals must be 18 years or older and have experienced either an ischemic stroke (caused by a blockage) or a hemorrhagic stroke (caused by bleeding) within the last six months. They should have a certain level of balance and cognitive ability, as measured by specific tests. However, those with severe vision or hearing problems, certain neurological disorders, or other serious health issues will not be eligible. Participants can expect to engage in the exercise programs and will be assessed on their balance and walking abilities throughout the trial. This study aims to provide valuable insights into effective rehabilitation strategies for stroke survivors.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Had ischemic or haemorrhagic stroke ≤6 months
- • Berg Balance Scale (BBS) score between 35 and 45
- • Dynamic Gait Index score between 11 and 19
- • Mini-mental status exam scores \> 24
- Exclusion Criteria:
- • Participants with severe vision or hearing impairment
- • Neurological disorders including epilepsy, Alzheimer's disease, vertigo, Parkinson disease, and stroke, muscular disorders which limit functional activity (OA, RA, etc)
- • Medications that affect balance, severe cardiovascular conditions, recent lower limb injury or surgery
- • Peripheral vestibular disorder
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Islamabad, Fedral, Pakistan
Patients applied
Trial Officials
Dr.Zeest Hashmi, MSNMPT
Principal Investigator
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported